← Back to Search

Development of a Metabolic Assessment Tool for Chronic Kidney Disease

N/A
Waitlist Available
Led By J. Bruce German, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline vs. 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to examine the variation between individuals in blood lipid metabolites, and the changes in these metabolites in response to omega-3 fatty acids in patients with immunoglobulin A nephropathy (IgAN) and in healthy subjects. The hypothesis is that measuring variation among individuals and changes in response to omega-3 fatty acids comprehensively by using metabolomics will help to identify those individuals who are responders and those who are non-responders to omega-3 fatty acids as an anti-inflammatory intervention.

Eligible Conditions
  • IgA Nephropathy
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline vs. 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline vs. 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lipids
Secondary study objectives
PBMC gene expression
Other study objectives
Urinary oxylipins

Side effects data

From 2007 Phase 1 & 2 trial • 39 Patients • NCT00090402
15%
Dizziness
15%
cold
8%
Falls
8%
Heart Failure
100%
80%
60%
40%
20%
0%
Study treatment Arm
Fish Oil
Fish Oil Plus Lipoic Acid
Placebo

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fish oilExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fish Oil
2006
Completed Phase 4
~1320

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
946 Previous Clinical Trials
4,756,118 Total Patients Enrolled
J. Bruce German, PhDPrincipal InvestigatorUniversity of California, Davis
4 Previous Clinical Trials
88 Total Patients Enrolled
Bruce D Hammock, PhDPrincipal InvestigatorUniversity of California, Davis
1 Previous Clinical Trials
6 Total Patients Enrolled
Angela M Zivkovic, PhDPrincipal InvestigatorUniversity of California, Davis
2 Previous Clinical Trials
72 Total Patients Enrolled
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top